10-88583080-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001031709.3(RNLS):​c.111G>C​(p.Glu37Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.443 in 1,608,540 control chromosomes in the GnomAD database, including 159,205 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 17133 hom., cov: 33)
Exomes 𝑓: 0.44 ( 142072 hom. )

Consequence

RNLS
NM_001031709.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: -0.517

Publications

90 publications found
Variant links:
Genes affected
RNLS (HGNC:25641): (renalase, FAD dependent amine oxidase) Enables several functions, including NADH binding activity; epinephrine binding activity; and monoamine oxidase activity. Involved in negative regulation of blood pressure and negative regulation of heart rate. Located in extracellular region. Implicated in essential hypertension and hypertension. Biomarker of end stage renal disease. [provided by Alliance of Genome Resources, Apr 2022]
LIPJ (HGNC:21773): (lipase family member J) Predicted to enable hydrolase activity, acting on ester bonds. Predicted to be involved in lipid catabolic process. Predicted to be active in intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.648983E-5).
BP6
Variant 10-88583080-C-G is Benign according to our data. Variant chr10-88583080-C-G is described in ClinVar as Benign. ClinVar VariationId is 1250700.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.517 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RNLSNM_001031709.3 linkc.111G>C p.Glu37Asp missense_variant Exon 1 of 7 ENST00000331772.9 NP_001026879.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RNLSENST00000331772.9 linkc.111G>C p.Glu37Asp missense_variant Exon 1 of 7 1 NM_001031709.3 ENSP00000332530.4

Frequencies

GnomAD3 genomes
AF:
0.472
AC:
71749
AN:
152042
Hom.:
17124
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.523
Gnomad AMI
AF:
0.614
Gnomad AMR
AF:
0.439
Gnomad ASJ
AF:
0.480
Gnomad EAS
AF:
0.434
Gnomad SAS
AF:
0.467
Gnomad FIN
AF:
0.548
Gnomad MID
AF:
0.506
Gnomad NFE
AF:
0.437
Gnomad OTH
AF:
0.468
GnomAD2 exomes
AF:
0.457
AC:
112796
AN:
246570
AF XY:
0.456
show subpopulations
Gnomad AFR exome
AF:
0.531
Gnomad AMR exome
AF:
0.465
Gnomad ASJ exome
AF:
0.476
Gnomad EAS exome
AF:
0.428
Gnomad FIN exome
AF:
0.538
Gnomad NFE exome
AF:
0.431
Gnomad OTH exome
AF:
0.445
GnomAD4 exome
AF:
0.439
AC:
640025
AN:
1456380
Hom.:
142072
Cov.:
43
AF XY:
0.440
AC XY:
318249
AN XY:
723934
show subpopulations
African (AFR)
AF:
0.530
AC:
17585
AN:
33186
American (AMR)
AF:
0.460
AC:
20260
AN:
44090
Ashkenazi Jewish (ASJ)
AF:
0.478
AC:
12421
AN:
25996
East Asian (EAS)
AF:
0.417
AC:
16443
AN:
39436
South Asian (SAS)
AF:
0.463
AC:
39715
AN:
85720
European-Finnish (FIN)
AF:
0.530
AC:
28269
AN:
53294
Middle Eastern (MID)
AF:
0.493
AC:
2836
AN:
5748
European-Non Finnish (NFE)
AF:
0.429
AC:
475615
AN:
1108812
Other (OTH)
AF:
0.447
AC:
26881
AN:
60098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
17639
35278
52916
70555
88194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14628
29256
43884
58512
73140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.472
AC:
71791
AN:
152160
Hom.:
17133
Cov.:
33
AF XY:
0.475
AC XY:
35346
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.523
AC:
21697
AN:
41512
American (AMR)
AF:
0.439
AC:
6719
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.480
AC:
1668
AN:
3472
East Asian (EAS)
AF:
0.434
AC:
2242
AN:
5162
South Asian (SAS)
AF:
0.467
AC:
2252
AN:
4822
European-Finnish (FIN)
AF:
0.548
AC:
5807
AN:
10588
Middle Eastern (MID)
AF:
0.517
AC:
152
AN:
294
European-Non Finnish (NFE)
AF:
0.437
AC:
29711
AN:
67986
Other (OTH)
AF:
0.465
AC:
983
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
2033
4067
6100
8134
10167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
654
1308
1962
2616
3270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.419
Hom.:
9970
Bravo
AF:
0.467
TwinsUK
AF:
0.417
AC:
1547
ALSPAC
AF:
0.428
AC:
1651
ESP6500AA
AF:
0.537
AC:
2367
ESP6500EA
AF:
0.434
AC:
3735
ExAC
AF:
0.460
AC:
55835
Asia WGS
AF:
0.460
AC:
1602
AN:
3478
EpiCase
AF:
0.428
EpiControl
AF:
0.430

ClinVar

Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 20975995, 23116393, 27434211, 22812913, 24923329, 26309615, 29065134, 17216203) -

Stage 5 chronic kidney disease Other:1
-
Bioinformatics & Molecular Biology Unit, Faculty of Science, Al-Azhar University
Significance:association
Review Status:no assertion criteria provided
Collection Method:case-control

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
13
DANN
Uncertain
0.99
DEOGEN2
Benign
0.012
.;T;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.81
T;T;T
MetaRNN
Benign
0.000026
T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
-0.42
N;N;.
PhyloP100
-0.52
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-1.4
N;N;N
REVEL
Benign
0.073
Sift
Benign
0.49
T;T;T
Sift4G
Benign
0.19
T;T;T
Polyphen
0.19
B;B;.
Vest4
0.037
MutPred
0.12
Loss of helix (P = 0.0626);Loss of helix (P = 0.0626);Loss of helix (P = 0.0626);
MPC
0.11
ClinPred
0.0096
T
GERP RS
-0.83
PromoterAI
0.12
Neutral
Varity_R
0.13
gMVP
0.33
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2296545; hg19: chr10-90342837; COSMIC: COSV59290594; COSMIC: COSV59290594; API